Sign up to save your podcasts
Or
Share Building World-Class Biomedical Research Institutions with Dr. Edison Liu (Part 2)
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Building World-Class Biomedical Research Institutions with Dr. Edison Liu (Part 2)
Dr. Edison Liu is a medical doctor turned cancer geneticist, whose work focuses on cancer genomics, breast cancer biology, and translational medicine. He has held senior leadership roles in biomedical research institutions in the United States and Asia, as the founding executive director of the Genome Institute of Singapore (GIS), and later the president and CEO of the Jackson Laboratory, one of the world's leading genetics research institutions. Along the way, he helped shape Singapore's biomedical landscape, led genomics research through crises like SARS, and expanded global position medicine efforts across Asia and North America.
In Part 2, Dr. Edison Liu covers covers accountability and KPIs for Singapore’s biomedical initiative and how the 2003 SARS crisis validated translational research and GIS’s role, leading to recognition, embedding in MOH pandemic planning, and expanded work on H1N1/H5N1, Chikungunya, and Dengue. He shares that Singapore engineered healthcare as a discovery engine that supports economic welfare through pandemic control, precision medicine, and healthy aging, contrasting Singapore’s efficient population-based system with the US. He describes Singapore’s planned hospital/research cluster model versus evolving academic medical centers in the US, then explains leaving GIS after 11 years after developing successors. He recounts leading Jackson Laboratory’s transformation from 2012, scaling revenues and endowment and expanding campuses internationally, and emphasizes leadership traits (risk-taking, humility, learning), self-sufficiency in training, PhD reform, and Singapore’s bilingual role bridging a “two-systems” world while noting small size can enable global excellence.
Host: John Joson Ng
Editors: Dillon Chew, Hana Maldivita Tambrin, Shamieraah Jamal, Vasilina Gedzun
Chapters:
02:40 KPI and doubts
05:25 Health as Economic Engine
09:50 Knowing When to Step Down
13:10 Why join JAX
14:01 Scaling JAX Globally
18:15 Leadership Traits for Scientists
21:10 Rethinking the PhD in today’s era
26:10 Singapore and Asia's Biotech Future
View all episodes
By Nucleate SingaporeDr. Edison Liu is a medical doctor turned cancer geneticist, whose work focuses on cancer genomics, breast cancer biology, and translational medicine. He has held senior leadership roles in biomedical research institutions in the United States and Asia, as the founding executive director of the Genome Institute of Singapore (GIS), and later the president and CEO of the Jackson Laboratory, one of the world's leading genetics research institutions. Along the way, he helped shape Singapore's biomedical landscape, led genomics research through crises like SARS, and expanded global position medicine efforts across Asia and North America.
In Part 2, Dr. Edison Liu covers covers accountability and KPIs for Singapore’s biomedical initiative and how the 2003 SARS crisis validated translational research and GIS’s role, leading to recognition, embedding in MOH pandemic planning, and expanded work on H1N1/H5N1, Chikungunya, and Dengue. He shares that Singapore engineered healthcare as a discovery engine that supports economic welfare through pandemic control, precision medicine, and healthy aging, contrasting Singapore’s efficient population-based system with the US. He describes Singapore’s planned hospital/research cluster model versus evolving academic medical centers in the US, then explains leaving GIS after 11 years after developing successors. He recounts leading Jackson Laboratory’s transformation from 2012, scaling revenues and endowment and expanding campuses internationally, and emphasizes leadership traits (risk-taking, humility, learning), self-sufficiency in training, PhD reform, and Singapore’s bilingual role bridging a “two-systems” world while noting small size can enable global excellence.
Host: John Joson Ng
Editors: Dillon Chew, Hana Maldivita Tambrin, Shamieraah Jamal, Vasilina Gedzun
Chapters:
02:40 KPI and doubts
05:25 Health as Economic Engine
09:50 Knowing When to Step Down
13:10 Why join JAX
14:01 Scaling JAX Globally
18:15 Leadership Traits for Scientists
21:10 Rethinking the PhD in today’s era
26:10 Singapore and Asia's Biotech Future